ABT

Company overview unavailable

$101.29

+$0.22 (+0.22%)

Last close · 2026-09-25

Free AI rating for ABT

See QuantAdvisor's buy/sell/hold call and the reasoning — no account needed.

Price history

Daily closing prices for ABT.

+$8.58 (+9.25%) over the last 3m

$120.00$120.00$115.00$115.00$110.00$110.00$105.00$105.00$100.00$100.00$95.00$95.00$90.00$90.00$85.00$85.002026-06-292026-06-292026-07-132026-07-132026-07-242026-07-242026-08-062026-08-062026-08-192026-08-192026-09-012026-09-012026-09-152026-09-15

Related news

Recent coverage of ABT.

Best Dividend Kings: September 2026

Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain.

SeekingAlpha · 1d ago

NVST vs. ABT: Which Stock Is the Better Value Option?

NVST vs. ABT: Which Stock Is the Better Value Option?

Yahoo · 2d ago

How To Build A $75,000 Dividend Portfolio With SCHD And 5 High-Yield Picks

Build a $75K dividend portfolio anchored by SCHD, enhanced with JEPI, VNG, and 8 quality stocks to boost yield, growth, and diversification—read now.

SeekingAlpha · 2d ago

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

Abbott (ABT) concluded the recent trading session at $101.07, signifying a -2.34% move from its prior day's close.

Yahoo · 2d ago

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery

Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the letter here. The Tributary Multi Cap Core’s equity allocation underperformed in Q2, returning +12.5% against +15.3% for the S&P 1500 and +15.4% for the Russell 3000. Information Technology was the main driver of […]

Yahoo · 3d ago

TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher

Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "TDM Reagent Kit Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global TDM Reagent Kit Market, projected to reach USD 2.87 billion in 2026 and grow at a CAGR of 15.84% to USD 6.96 billion

Yahoo · 3d ago

FDA Advisors Said It Should Approve the Grail Multicancer Blood Test

Grail stock rose 35% this week as the Food and Drug Administration considers the company’s cancer blood test.

Yahoo · 3d ago

Is Abbott’s Digital Health Push and Formula Settlement Altering The Investment Case For Abbott (ABT)?

In recent weeks, Abbott and Berry Street announced an exclusive partnership that combines Abbott’s Lingo over-the-counter continuous glucose monitor with Berry Street’s insurance-covered virtual nutrition coaching, while Abbott’s Volt Pulsed Field Ablation System saw first clinical use in Canada and at UnityPoint Health – Trinity Heart Center in Illinois for treating atrial fibrillation. Alongside these developments, Abbott’s agreement to pay about US$385,000,000 to settle infant formula...

Yahoo · 4d ago

Key statistics

Company fundamentals are temporarily unavailable.

StockTwits chatter

What traders are saying on StockTwits right now

No StockTwits chatter available right now.

Source: StockTwits

Community

Recent posts mentioning ABT.

Sign in to join the QuantAdvisor conversation on ABT — post your take, like and follow.

Data may be delayed. For research, not financial advice.

© 2026 QuantAdvisor. All rights reserved.